APA (7th ed.) Citation

L, G., T, K., S, K., A, R., P, J., S, M., . . . D, R. (2023). Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors. ELife, 12, . https://doi.org/10.7554/eLife.82184

Chicago Style (17th ed.) Citation

L, Goebel, et al. "Targeting Oncogenic KRasG13C with Nucleotide-based Covalent Inhibitors." ELife 12 (2023). https://doi.org/10.7554/eLife.82184.

MLA (9th ed.) Citation

L, Goebel, et al. "Targeting Oncogenic KRasG13C with Nucleotide-based Covalent Inhibitors." ELife, vol. 12, 2023, https://doi.org/10.7554/eLife.82184.